Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine + pseudoephedrine crossover pollen chamber study in seasonal allergic rhinitis
2007-001587-70Phase 3Completed
- Sponsor
- Fraunhofer-Gesellschaft
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cetirizine and pseudoephedrine in seasonal allergic rhinitis (SAR) (2 arms), sponsored by Fraunhofer-Gesellschaft. Primary endpoint: Change in total nasal symptom score. Started Apr 2007; status: completed.
02
Drugs
cetirizinepseudoephedrine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on 2007-001587-70.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001587-70.